To evaluate the association of variants related to spermatogenesis with susceptibility to Chinese idiopathic nonobstructive azoospermia (NOA), seventeen tag single-nucleotide polymorphisms (SNPs) in CREM, ACT, KIF17b, and SPAG8 were analyzed in 361 NOA patients and 368 controls by Sequenom iplex technology. The results showed that two CREM SNPs, rs4934540 and rs22954152, were significantly associated with NOA
INTRODUCTION
Infertility is a major health problem affecting about 10% of couples worldwide, and almost half of these cases resulted from male factor [1, 2] . Increasing evidences in combination with our previous investigations indicated that genetic variations or susceptibility might play a crucial role in male infertility [3] [4] [5] . Nonobstructive azoospermia (NOA) is one of the most severe phenotype of male infertility. A recent genomewide association study identified three risk loci (rs12097821 at 1p13.3, rs2477686 at 1p36. 32 , and rs10842262 at 12p12.1) for NOA [6] . However, a larger panel of the heritability of NOA was not yet well explained by the genomewide association study. Although some of NOA patients can get their babies through Intracytoplasmic sperm injection, the genetic risk cannot be ignored.
Knockout of cAMP-response element modulator (CREM) gene leads to infertility in transgenic animals where spermatogenesis comes to a halt at the round spermatid level. It has been shown that Crem is essential for spermatogenesis in mice [7] . The CREM transcription factor is highly expressed in postmeiotic male germ cells in mouse and humans. and for this reason, it was initially thought to be an important regulatory factor during spermatogenesis [8, 9] . As a master transcriptional activator during spermatogenesis, CREM mediates the transcription of many postmeiotic genes (e.g., TNP1, TNP2, PRM1, and PRM2) via binding the cAMP-response element in their promoters. These gene products are responsible for chromatin remodeling, spermatid elongation, and cell apoptosis [10, 11] .
The transcriptional activity of CREM in testis is mainly activated by its coactivator, activator of CREM in the testis (ACT) [12] . ACT is a member of the four-and-a-half LIM domain family of proteins. Each LIM contains two zinc finger motifs. The LIM proteins participate in a variety of diverse processes related to cytoskeletal function and control of gene expression. The CREM-ACT complex mediates the expression of postmeiotic genes that are essential for normal spermatogenesis, providing a tissue-specific modulation mechanism for CREM transcription activity [12] . The ACT protein also interacts with other proteins. Two independent groups demonstrated that ACT binds to KIF17b, a kinesin motor protein. It appears that KIF17b plays an indirect role in the regulation of CREM activation by shuttling ACT out of the nucleus and transporting it into the cytoplasm, where it can no longer activate CREM-dependent transcription [13, 14] . The data from other study groups demonstrated that KIF17b physically interacts with MIWI, a testis-specific member of the PIWI/Argonaute family and plays an essential role in the formation of chromatoid bodies in haploid germ cells [15] . Sperm-associated antigen 8 (SPAG8), a novel regulator of activator of CREM in testis during spermatogenesis, has been identified recently [16] . SPAG8 enhances the transcriptional activation of ACT-mediated CREM by strengthening the binding of ACT to CREM. These findings indicate that SPAG8 acts as a regulator of ACT and plays an important role in CREM-ACT-mediated gene transcription during spermatogenesis.
Based on the previous functional investigations on genes in CREM pathway in spermatogenesis described above, we performed a genotyping analysis for 17 potential singlenucleotide polymorphisms (SNPs) of CREM, ACT, KIF17b, and SPAG8 genes in a case-control study of NOA in the Chinese population. We addressed whether the polymorphisms in CREM pathway genes were associated with the risk of infertility in the Chinese population. Meanwhile, we analyzed CREM mRNA expression in maturation arrest patients and controls with normal spermatogenesis.
MATERIALS AND METHODS

Study Population
This study contained 361 NOA patients (ages ranged from 19 to 43 yr) and 368 fertile controls (ages ranged from 20 to 53 yr). The patients recruited in this study were strictly screened. At least two semen samples for each patient were analyzed to confirm the diagnosis of azoospermia, which is defined as the absence of sperm in ejaculate after centrifugation at 3000 3 g for 15 min [17] .
The diagnosis was based on comprehensive andrological examination, including medical history, physical examination, semen analysis, hormone analysis, karyotyping, and Y microdeletion analysis. Patients with history of orchitis, epididymitis, maldescensus of the testis, mono-or bilateral cryptorchidism, varicocele, hypogonadotrophic hypogonadism, obstruction or absence of vas deferens, chromosomal abnormalities, and Y chromosome microdeletions [18] were carefully excluded from this study. The controls consisted of 368 normozoospermia men who had fathered at least one healthy child. All the patients and controls were drawn from the same hospital.
To detect the mRNA expression of CREM gene in the NOA patients and the controls, we collected 30 testicular tissues from NOA patients of maturation arrest and 27 testicular tissues from obstructive azoospermia (OA) patients with normal spermatogenesis. All the samples used in this study were obtained during routine testicular biopsy for diagnostic or therapeutic testicular sperm extraction reasons.
The patients and the controls enrolled in this study were all provided written informed consent for the collection of samples and subsequent analysis. This study was conducted in accordance with the tenets of the Declaration of Helsinki and its amendments and approved by the ethics committee of Anhui Medical University (ECAMU No 2008035).
Extraction of Peripheral Blood DNA
Blood sample was collected from each subject in 5.2 mM ethylenediaminetetraacetic acid and stored at À808C. Genomic DNA was extracted from the blood using QIAamp DNA Blood Midi Kit (Qiagen Inc.) according to the manufacturer's protocol. The quantitative concentration of DNA was measured by the Nanodrop Spectrophotometer (ND-2000) of full wavelength and standardized to 15-20 ng/ll.
SNP Selection and Sequenom Assay
We selected 17 SNPs in this study, including four SNPs of CREM (rs4934540, rs2295415, rs11592356, and rs1148247), nine SNPs of ACT (rs2273621, rs9373985, rs2252816, rs9398152, rs9398148, rs4839688, rs17056756, rs3798292, and rs9486705), three SNPs of KIF17b (rs631357, rs522496, and rs2296225) and one SNP of SPAG8 (rs3763631). The selection criteria for the 17 candidate SNPs were 1) minor allele frequency (MAF) ! 5% according to the HapMap database of the Chinese Han population, and 2) all the selected SNPs are tag SNPs [19] , which were selected by Haploview software. All the SNPs were genotyped using mass spectrometry (Sequenom Inc.) according to the manufacturer's guidelines. The SNP detected with a call rate lower than 90% in the cases and controls or beyond the Hardy-Weinberg equilibrium in the controls (P, 0.01) were excluded.
Histological Analysis
Testicular biopsies from the patients were stained by hematoxylin-eosin to confirm the histological phenotype and the diagnosis. Biopsies were histologically evaluated and classified as normal spermatogenesis (n ¼ 27) and maturation arrest (n ¼ 30) according to the Johnson score [20] . Testicular tissues from OA patients contained all the stages of germ cell development, including the formation of testicular spermatozoa (Fig. 1A) , while maturation arrest displayed an absence of germ cell at the later stages of spermatogenesis (Fig. 1B) .
RNA Extraction and Real-Time PCR
Total RNA from human testicular samples was extracted with Trizol (Invitrogen). For real-time PCR assays, RNA was reverse-transcribed into cDNA using the PrimeScript RT reagent kit (TaKaRa Bio, Inc.) according to the manufacturer's instructions. Real-time PCR was performed on the ABI Step One System (Applied Biosystems) using the SYBR Premix Ex Taq II kit (TaKaRa Bio, Inc.) following the manufacturer's protocols. The relative expression levels of CREM were normalized to b-actin. The primer sequences 
Statistical Analysis
The Hardy-Weinberg equilibrium was determined by the controls. In addition, the genetic models (addictive, dominant, and recessive) were analyzed for the associated SNPs. The statistical software Plink v1.07 (http:// pngu.Mgh.Harvard. edu/purcell/plink/) and Stata/SE version 10 (Stata Corp LP) were used for the statistical analyses. Bonferroni correction was used to correct the P-values of the allele frequency and genotype of each SNP. Student t-test was used to compare the relative mRNA expression of CREM in the testicular tissues between the NOA cases and the controls. The P values reported in the study were based on two-sided probability test with a significance level of P , 0.05.
RESULTS
Characteristics of the Study Population
Clinical characteristics of 361 patients of NOA and 368 controls are shown in Table 1 . The testes' volume in NOA was significantly smaller than that in the controls (P , 0.001). The body mass index (BMI) between the two groups was found to be not significantly different.
Polymorphisms of the Genes and Risk of NOA
In this study, we investigated 17 SNPs in the ACT, CREM, Kif17b, and SPAG8 genes, all of which were in coherence with the assumption of the Hardy-Weinberg equilibrium (P . 
Haplotypes of the CREM-Signaling Genes and Risk of NOA
We further analyzed the haplotypes of the CREM gene. The results indicated that the haplotype distributions of the four SNPs (rs4934540, rs2295415, rs11592356, and rs1148247) in the CREM gene between the cases and the controls significantly differed. Table 4 shows that the haplotype CGTG offered a significantly protective effect on spermatogenesis (P ¼ 0.001, OR ¼ 0.659, 95%CI ¼ 0.509-0.853). In contrast, the haplotype TATG exhibited significantly increased risk of spermatogenic failure (P ¼ 0.011, OR ¼ 1.137, 95%CI ¼ 1.064-1.631). We analyzed the haplotypes of ACT and Kif17b genes, respectively, but found no associations with NOA (Supplemental Table S1 and Supplemental Table S2 ; available online at www.biolreprod.org). 
CREM VARIANTS CONFERRED SUSCEPTIBILITY TO NOA
CREM Expression in Testis Tissue of Maturation Arrest and Normal Spermatogenesis
We performed a quantitative RT-PCR assay to evaluate the transcriptional expression of CREM gene in 30 additional NOA patients with maturation arrest and 27 OA with normal spermatogenesis (Fig. 2) . The result showed that mean relative mRNA level of CREM in the OA group with normal spermatogenesis was 0.864 6 0.073 (n ¼ 27). The relative mRNA level of CREM in the maturation arrest group was significantly attenuated to 0.294 6 0.049 (n ¼ 30), quantitatively, which was only one-third of that in the controls with normal spermatogenesis (P , 0.0001).
DISCUSSION
This study examined the association of SNPs in the candidate genes of CREM pathway with NOA susceptibility. Our data revealed that none of the candidate SNPs of ACT, KIF17b, and SPAG8 showed significant association with the risk of NOA in the Chinese population. However, the results demonstrated that the SNPs rs4934540 and rs2295415 of the CREM gene significantly led to a decreased susceptibility to NOA risk, indicating that the two SNPs might be protective factors for spermatogenesis. In addition, we analyzed the genotype distributions of the two associated SNPs and observed that positive effects on male fertility occurred in the individuals with C variant of rs4934540 (CC or CT) and G variant of rs2295415 (AG or GG). The SNP rs2295415 is located at the 3 0 untranslated region of CREM gene. According to the Web-based SNP analysis tool MirSNP [21] , rs2295415 might be the binding site of some micro-RNAs which might influence the posttranscriptional regulation. Furthermore, we predicted the splicing regulation activity of rs2295415 with ESEfinder [22] and found that the A to G change of rs2295415 might affect splicing of CREM. Also, the analysis conducted by the TFSearch [23] , a transcription factor prediction tool, indicated that the T to C change of rs4934540 might change the gene transcriptional activity (activation/repression). Our data provided new evidence that the two variants played protective roles in NOA risk. Further functional study for rs4934540 and rs2295415 of the CREM gene would be useful to reveal the molecular mechanisms of the two SNPs on male infertility.
To investigate the potential combination effects of SNPs of CREM-signaling genes on risk of NOA, we analyzed haplotypes of ACT, Kif17b, and CREM variants, independently. Although most haplotype frequencies such as ACT and Kif17b variants were beyond significant associations between the cases and the controls, we found the frequency of the haplotype CGTG of the CREM gene was significantly higher in the fertile group than that in impaired spermatogenesis (P ¼ 0.001), indicating that the haplotype CGTG might either be a protective factor against susceptibility to the NOA or play a natural selection role in favor of the haplotype CGTG to the normal sperm output. A previous case-control study in individuals of European ancestry, which consisted of 96 impaired spermatogenesis patients (47 men with azoospermia and 49 men with severe oligozoospermia) and 69 fertile controls, suggested that different haplotypes within the ACT gene might contribute to idiopathic male infertility [24] . In this study, none of ACT variants showed significant associations with the risk of NOA in the Chinese population. The reasons for the divergent results remains unknown. It could be attributed to either the smaller panel of European samples or differences in the two populations.
Previous studies showed that testicular CREM protein was expressed in round spermatids in stages I-III of spermatogenesis [7, 25] . A Crem-deficient mice model indicated Crem might be involved in initiating the elongation process in postmeiotic spermatids in human. Among the patients with predominant round spermatid maturation arrest, CREM expression was significantly reduced [25, 26] . Similarly, our data revealed that the mRNA level of CREM of NOA patients with maturation arrest was dramatically reduced relative to that of the controls with normal spermatogenesis. In consideration with the genetic analysis in this study, we supposed that rs4934540 and rs2295415 in CREM gene would be involved in aberrant CREM mRNA expression. On the other hand, it was demonstrated that expression of some chromatin-remodeling factors [27] and postmeiotic genes [28, 29] were significantly changed in the maturation arrest patients. Interestingly, regulations of the most of these genes were CREM dependent [11, 14] because it is a key transcriptional activator during spermatogenesis. Aberrant CREM change might directly interfere with the expression of its related genes and induce a complete arrest of spermatogenesis. The individuals enrolled in this study had rigorous inclusion and exclusion criteria. All the azoospermia with any known causes such as orchitis, epididymitis, varicocele, obstruction or absence of vas deferens, chromosomal abnormalities, and Y chromosome microdeletions were carefully excluded. Although many studies reported that obesity can decrease semen parameters [30, 31] and overweight or obesity can deteriorate the incidence of azoospermia or oligozoospermia [32] , the azoospermia patients in this study should not be associated with overweight or obesity because we measured the BMI for both the cases and the controls and found that the BMI was not significantly different between the two groups.
In conclusion, we found that the CREM polymorphisms rs4934540 and rs2295415 were significantly associated with the risk of NOA in the Chinese population. We supposed that the variants rs4934540 and rs2295415 might be involved in attenuating the CREM mRNA expression, which would give rise to the spermatogenesis maturation arrest. Our findings provided a new insight into the etiology and the diagnosis of NOA.
FIG. 2.
Quantified polymerase chain reaction analysis of the mRNA level of the cyclic AMP-responsive element modulator (CREM) in the controls with normal spermatogenesis and NOA patients with maturation arrest. Relative mRNA expression of CREM in maturation arrest group was 0.294 6 0.049 (n ¼ 30), compared with normal spermatogenesis group (0.864 6 0.073, n ¼ 27). Data are expressed as means 6 SD. Significance between two groups generated by the independent-samples t-test: P , 0.0001.
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